Abstract:Paclitaxel (trade name Taxol) is a rare diterpenoid with anticancer activity isolated from Taxus . At present, paclitaxel is mainly produced by the semi-synthetic method using extract of Taxus tissues as raw materials. The studies of regulatory mechanisms in paclitaxel biosynthesis would promote the production of paclitaxel through tissue/cell culture approaches. Here, we systematically identified 990 transcription factors (TFs), 460 microRNAs (miRNAs), and 160 phased small interfering RNAs (phasiRNAs) in Taxus chinensis to explore their interactions and potential roles in regulation of paclitaxel synthesis. The expression levels of enzyme genes in cone and root were higher than those in leaf and bark. Nearly all enzyme genes in the paclitaxel synthesis pathway were significantly up-regulated after jasmonate treatment, except for GGPPS and CoA Ligase . The expression level of enzyme genes located in the latter steps of the synthesis pathway was significantly higher in female barks than in male. Regulatory TFs were inferred through co-expression network analysis, resulting in the identification of TFs from diverse families including MYB and AP2. Genes with ADP binding and copper ion binding functions were overrepresented in targets of miRNA genes. The miRNA targets were mainly enriched with genes in plant hormone signal transduction, mRNA surveillance pathway, cell cycle and DNA replication. Genes in oxidoreductase activity, protein-disulfide reductase activity were enriched in targets of phasiRNAs. Regulatory networks were further constructed including components of enzyme genes, TFs, miRNAs, and phasiRNAs. The hierarchical regulation of paclitaxel production by miRNAs and phasiRNAs indicates a robust regulation at post-transcriptional level. Our study on transcriptional and posttranscriptional regulation of paclitaxel synthesis provides clues for enhancing paclitaxel production using synthetic biology technology.

[Advances in paclitaxel biosynthesis and transcriptional regulation mechanisms]

Biosynthesis of paclitaxel using synthetic biology

Advances On Paclitaxel Biosynthesis In Taxus

Biosynthesis and Regulation of Paclitaxel in Taxus

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Strategies Of Improving Paclitaxel Biosynthesis In Taxus

Recent advances in paclitaxel biosynthesis and regulation

Post-genomic illumination of paclitaxel biosynthesis

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Regulatory microRNAs and phasiRNAs of paclitaxel biosynthesis in Taxus chinensis

A new era for paclitaxel biosynthesis is coming

Mining natural products related to paclitaxel reveals the possible biosynthetic pathway of paclitaxel

Medicinal Chemistry of Paclitaxel and Its Analogues

Intricate Metabolic Network for Paclitaxel Biosynthesis

Paclitaxel: A Landmark Natural Anticancer Drug

Transcriptome and comparative chloroplast genome analysis of Taxus yunnanensis individuals with high and low paclitaxel yield

Research Progress of Paclitaxel Drug Source Solution and Extraction and Separation Technology

Reconstitution of early paclitaxel biosynthetic network

Recent Research Progress in Taxol Biosynthetic Pathway and Acylation Reactions Mediated by Taxus Acyltransferases

Progress in research on paclitaxel and tumor immunotherapy

The Taxus genome provides insights into paclitaxel biosynthesis